Literature DB >> 11739679

Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection.

Udayasankar Kumaraguru1, Malgorzata Gierynska, Shanna Norman, Barry D Bruce, Barry T Rouse.   

Abstract

Heat shock proteins loaded with viral peptides were shown to induce a CD8+ T cell response and confer protective immunity against challenge with herpes simplex virus (HSV). The delivery system consisted of recombinant human hsp70 coupled to the peptide SSIEFARL, which is the immunodominant peptide epitope, recognized by HSV specific T cells in C57BL/6 mice. Immunization resulted in CD8+ T-cell responses, measured by peptide-specific tetramers and peptide-induced intracellular gamma interferon expression and cytotoxicity, similar to responses resulting from immunization with a recombinant vaccinia virus that expressed SSIEFARL as a minigene (VvgB) and UV-inactivated HSV. However, the durability of the hsp70-SSIEFARL response was less than that resulting from VvgB and HSV immunization and in addition the CD8+ T-cell responses in the memory phase were functionally less effective. Mice challenged soon after immunization showed excellent immunity, but by 90 days postimmunization this had waned to be significantly less than the level of immunity in both VvgB- and HSV-immunized mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739679      PMCID: PMC135705          DOI: 10.1128/jvi.76.1.136-141.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Application of the intracellular gamma interferon assay to recalculate the potency of CD8(+) T-cell responses to herpes simplex virus.

Authors:  U Kumaraguru; B T Rouse
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine.

Authors:  A Asea; S K Kraeft; E A Kurt-Jones; M A Stevenson; L B Chen; R W Finberg; G C Koo; S K Calderwood
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

3.  The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.

Authors:  M E Wallace; R Keating; W R Heath; F R Carbone
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system.

Authors:  U Kumaraguru; I A Davis; S Deshpande; S S Tevethia; B T Rouse
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

5.  HSP70 peptidembearing and peptide-negative preparations act as chaperokines.

Authors:  A Asea; E Kabingu; M A Stevenson; S K Calderwood
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

6.  Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.

Authors:  L M Mylin; T D Schell; D Roberts; M Epler; A Boesteanu; E J Collins; J A Frelinger; S Joyce; S S Tevethia
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

Authors:  J E Blaney; E Nobusawa; M A Brehm; R H Bonneau; L M Mylin; T M Fu; Y Kawaoka; S S Tevethia
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96.

Authors:  S Janetzki; N E Blachere; P K Srivastava
Journal:  J Immunother       Date:  1998-07       Impact factor: 4.456

9.  Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70.

Authors:  Y Moroi; M Mayhew; J Trcka; M H Hoe; Y Takechi; F U Hartl; J E Rothman; A N Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways.

Authors:  F Castellino; P E Boucher; K Eichelberg; M Mayhew; J E Rothman; A N Houghton; R N Germain
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  15 in total

1.  Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.

Authors:  Amy D H Doody; Joseph T Kovalchin; Marianne A Mihalyo; Adam T Hagymasi; Charles G Drake; Adam J Adler
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

2.  High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules.

Authors:  Toyoshi Matsutake; Tatsuya Sawamura; Pramod K Srivastava
Journal:  Cancer Immun       Date:  2010-08-02

3.  Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.

Authors:  Xiuli Zhang; Annie Issagholian; Eric A Berg; Jordan B Fishman; Anthony B Nesburn; Lbachir BenMohamed
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Hsp110-mediated enhancement of CD4+ T cell responses to the envelope glycoprotein of members of the family Flaviviridae in vitro does not occur in vivo.

Authors:  Kerry McLaughlin; Veronica B Carr; Munir Iqbal; Julian Seago; Eric A Lefevre; Lucy Robinson; Helen Prentice; Bryan Charleston
Journal:  Clin Vaccine Immunol       Date:  2010-12-08

5.  An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus.

Authors:  Christopher D Pack; Malgorzata Gierynska; Barry T Rouse
Journal:  Hum Vaccin       Date:  2008-09-28

6.  Hsp70 enhances presentation of FMDV antigen to bovine CD4+ T cells in vitro.

Authors:  Kerry McLaughlin; Julian Seago; Lucy Robinson; Charles Kelly; Bryan Charleston
Journal:  Vet Res       Date:  2010-02-02       Impact factor: 3.683

7.  Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector.

Authors:  Yuanmei Ma; Yue Duan; Yongwei Wei; Xueya Liang; Stefan Niewiesk; Michael Oglesbee; Jianrong Li
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.

Authors:  David M Koelle; Amalia Magaret; Christopher L McClurkan; Michael L Remington; Terri Warren; Florentina Teofilovici; Anna Wald
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

9.  Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2.

Authors:  William J Muller; Nural N Orgun; Lichun Dong; David M Koelle; Meei-Li Huang; Sing Sing Way
Journal:  Arch Virol       Date:  2008-04-29       Impact factor: 2.574

10.  Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection.

Authors:  William J Muller; Lichun Dong; Adrian Vilalta; Benjamin Byrd; Kai M Wilhelm; Christopher L McClurkan; Michal Margalith; Chao Liu; David Kaslow; John Sidney; Alessandro Sette; David M Koelle
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.